ZENIVOL Trademark

Trademark Overview

On Wednesday, November 11, 2020, a trademark application was filed for ZENIVOL with the United States Patent and Trademark Office. The USPTO has given the ZENIVOL trademark a serial number of 79299184. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, September 7, 2022. This trademark is owned by ZELIRA THERAPEUTICS LIMITED. The ZENIVOL trademark is filed in the Pharmaceutical Products category with the following description:

Medical cannabis and derivatives thereof; medical and pharmaceutical preparations, including for use in treating insomnia
zenivol

General Information

Serial Number79299184
Word MarkZENIVOL
Filing DateWednesday, November 11, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, September 7, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical cannabis and derivatives thereof; medical and pharmaceutical preparations, including for use in treating insomnia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 4, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZELIRA THERAPEUTICS LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events

Event DateEvent Description
Tuesday, October 3, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, September 7, 2023FINAL DISPOSITION NOTICE SENT TO IB
Thursday, September 7, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sunday, December 25, 2022NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, September 7, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, September 7, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, September 7, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, May 23, 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, May 4, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 4, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sunday, March 13, 2022REFUSAL PROCESSED BY IB
Thursday, February 24, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, February 24, 2022REFUSAL PROCESSED BY MPU
Saturday, January 29, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, January 28, 2022NON-FINAL ACTION WRITTEN
Saturday, January 22, 2022ASSIGNED TO EXAMINER
Tuesday, December 8, 2020APPLICATION FILING RECEIPT MAILED
Friday, December 4, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 3, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

zenivol medical including treating insomnia preparations pharmaceutical cannabis derivatives thereof